000 | 00994 a2200313 4500 | ||
---|---|---|---|
005 | 20250513091448.0 | ||
264 | 0 | _c19960725 | |
008 | 199607s 0 0 eng d | ||
022 | _a0003-9926 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChertow, G M | |
245 | 0 | 0 |
_aCost-effectiveness of cancer screening in end-stage renal disease. _h[electronic resource] |
260 |
_bArchives of internal medicine _cJun 1996 |
||
300 |
_a1345-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
650 | 0 | 4 | _aLife Expectancy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMass Screening _xeconomics |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
700 | 1 | _aPaltiel, A D | |
700 | 1 | _aOwen, W F | |
700 | 1 | _aLazarus, J M | |
773 | 0 |
_tArchives of internal medicine _gvol. 156 _gno. 12 _gp. 1345-50 |
|
999 |
_c8650879 _d8650879 |